Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procaine injections for osteoarthritis in elderly
NCT06717724Phase 3Completed
- Sponsor
- Sf. Luca Chronic Disease Hospital
- Start
- Feb 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of procaine in osteoarthritis of the hip and knee osteoarthritis (OA) (2 arms), sponsored by Sf. Luca Chronic Disease Hospital. Primary endpoint: Pain Levels (Visual Analogue Scale) at Day 10. Started Feb 2024; status: completed.
02
Drugs
procaine
03
Conditions
osteoarthritis of the hipknee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06717724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06717724.